COP — ConocoPhillips
$150.80+3.55%
Last close: · regular session
Last 60 sessions
COP closed at $150.80 (+3.55%) on Oct 23, 2026. Active automatic shelf (S-3ASR, Jun 2026); dilution risk: low. Float: 1.2B shares. Latest SEC filing: SD on Sep 11, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for COP in the TickerWise workspace.
ConocoPhillips explores for, produces, transports, and markets crude oil, bitumen, natural gas, liquefied natural gas (LNG), and natural gas liquids worldwide. It primarily engages in the conventional and tight oil reservoirs, shale gas, heavy oil, LNG, oil sands, and other production operations. The company's portfolio includes unconventional plays in North America; conventional assets in North America, Europe, Asia, and Australia; various LNG developments; oil sands assets in Canada; and an inventory of conventional and unconventional exploration prospects. ConocoPhillips was founded in 1917 and is headquartered in Houston, Texas.
Company profile
- Sector: Energy
- Industry: Oil & Gas Exploration & Production
- Country: US
- Exchange: New York Stock Exchange
- Employees: 11,800
- Website: https://www.conocophillips.com
Latest SEC filings for COP
Latest COP news
- Here's How Much a $1000 Investment in ConocoPhillips Made 10 Years Ago Would Be Worth Today Read article
- COP vs. WHD: Which Stock Should Value Investors Buy Now? Read article
- Will ConocoPhillips (COP) Gain on Rising Earnings Estimates? Read article
- Here's Why ConocoPhillips (COP) is a Strong Momentum Stock Read article
- ConocoPhillips (COP) Ascends While Market Falls: Some Facts to Note Read article
- Why ConocoPhillips (COP) is a Top Value Stock for the Long-Term Read article
- ConocoPhillips (COP) Advances While Market Declines: Some Information for Investors Read article
- ConocoPhillips (COP) is a Top-Ranked Growth Stock: Should You Buy? Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.